126 related articles for article (PubMed ID: 38218346)
1. A Reason to be Positive: Early Cardiac Allograft Vasculopathy and Acute Rejection in Recipients of HCV+ Donor Hearts.
Dichiacchio L; Higgins AR
J Card Fail; 2024 May; 30(5):701-702. PubMed ID: 38218346
[No Abstract] [Full Text] [Related]
2. Cardiac allograft vasculopathy and secondary outcomes of hepatitis C-positive donor hearts at 1 year after transplantation.
Madan S; Patel SR; Jorde UP
J Heart Lung Transplant; 2020 Nov; 39(11):1318-1321. PubMed ID: 32680608
[No Abstract] [Full Text] [Related]
3. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
Amancherla K; Feurer ID; Rega SA; Cluckey A; Salih M; Davis J; Pedrotty D; Ooi H; Rali AS; Siddiqi HK; Menachem J; Brinkley DM; Punnoose L; Sacks SB; Zalawadiya SK; Wigger M; Balsara K; Trahanas J; McMaster WG; Hoffman J; Pasrija C; Lindenfeld J; Shah AS; Schlendorf KH
J Card Fail; 2024 May; 30(5):694-700. PubMed ID: 37907147
[TBL] [Abstract][Full Text] [Related]
4. Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors.
Kadosh BS; Birs AS; Flattery E; Stachel M; Hong KN; Xia Y; Gidea C; Aslam S; Razzouk L; Saraon T; Goldberg R; Rao S; Pretorius V; Moazami N; Smith DE; Adler ED; Reyentovich A
Clin Transplant; 2024 Apr; 38(4):e15294. PubMed ID: 38545881
[TBL] [Abstract][Full Text] [Related]
5. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.
Haji SA; Starling RC; Avery RK; Mawhorter S; Tuzcu EM; Schoenhagen P; Cook DJ; Ratliff NB; McCarthy PM; Young JB; Yamani MH
J Heart Lung Transplant; 2004 Mar; 23(3):277-83. PubMed ID: 15019636
[TBL] [Abstract][Full Text] [Related]
6. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
[TBL] [Abstract][Full Text] [Related]
7. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
[TBL] [Abstract][Full Text] [Related]
9. Impact of Traumatically Brain-Injured Donors on Outcomes After Heart Transplantation.
Suarez-Pierre A; Crawford TC; Zhou X; Lui C; Fraser CD; Etchill E; Sharma K; Higgins RS; Whitman GJ; Kilic A; Choi CW
J Surg Res; 2019 Aug; 240():40-47. PubMed ID: 30909064
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
Yamada K; Mawulawde K; Menard MT; Shimizu A; Aretz HT; Choo JK; Allison KS; Slisz JK; Sachs DH; Madsen JC
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):709-19. PubMed ID: 10733759
[TBL] [Abstract][Full Text] [Related]
11. The curious phenomenon of early cardiac allograft rejection with hepatitis C‒infected donor heart transplants.
Woolley AE; Singh SK
J Heart Lung Transplant; 2020 Nov; 39(11):1208-1209. PubMed ID: 32978057
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.
Gasink LB; Blumberg EA; Localio AR; Desai SS; Israni AK; Lautenbach E
JAMA; 2006 Oct; 296(15):1843-50. PubMed ID: 17047214
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
[TBL] [Abstract][Full Text] [Related]
14. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
[TBL] [Abstract][Full Text] [Related]
15. Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts.
Streblow DN; Hwee YK; Kreklywich CN; Andoh T; Denton M; Smith P; Hart E; Broekel R; Pallett C; Rogers K; Streblow AD; Chuop M; Perry A; Slifka M; Messaoudi I; Orloff SL
Am J Transplant; 2015 Jul; 15(7):1805-16. PubMed ID: 25766876
[TBL] [Abstract][Full Text] [Related]
16. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.
Krasinskas AM; Eiref SD; McLean AD; Kreisel D; Gelman AE; Popma SH; Moore JS; Rosengard BR
Transplantation; 2000 Aug; 70(3):514-21. PubMed ID: 10949196
[TBL] [Abstract][Full Text] [Related]
17. Increased early acute cellular rejection events in hepatitis C-positive heart transplantation.
Gidea CG; Narula N; Reyentovich A; Fargnoli A; Smith D; Pavone J; Lewis T; Karpe H; Stachel M; Rao S; Moreira A; Saraon T; Raimann J; Kon Z; Moazami N
J Heart Lung Transplant; 2020 Nov; 39(11):1199-1207. PubMed ID: 32739334
[TBL] [Abstract][Full Text] [Related]
18. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
[TBL] [Abstract][Full Text] [Related]
19. Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trial.
McLean RC; Reese PP; Acker M; Atluri P; Bermudez C; Goldberg LR; Abt PL; Blumberg EA; Van Deerlin VM; Reddy KR; Bloom RD; Hasz R; Suplee L; Sicilia A; Woodards A; Zahid MN; Bar KJ; Porrett P; Levine MH; Hornsby N; Gentile C; Smith J; Goldberg DS
Am J Transplant; 2019 Sep; 19(9):2533-2542. PubMed ID: 30768838
[TBL] [Abstract][Full Text] [Related]
20. Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry.
Khush KK; Kubo JT; Desai M
J Heart Lung Transplant; 2012 May; 31(5):459-66. PubMed ID: 22418079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
